Last reviewed · How we verify
Hiltonol and autologous dendritic cells
Hiltonol and autologous dendritic cells is a Biologic drug developed by Clinica Universidad de Navarra, Universidad de Navarra. It is currently in Phase 2 development.
At a glance
| Generic name | Hiltonol and autologous dendritic cells |
|---|---|
| Sponsor | Clinica Universidad de Navarra, Universidad de Navarra |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma (PHASE1)
- Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs (PHASE1, PHASE2)
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma (PHASE1)
- Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hiltonol and autologous dendritic cells CI brief — competitive landscape report
- Hiltonol and autologous dendritic cells updates RSS · CI watch RSS
- Clinica Universidad de Navarra, Universidad de Navarra portfolio CI
Frequently asked questions about Hiltonol and autologous dendritic cells
What is Hiltonol and autologous dendritic cells?
Hiltonol and autologous dendritic cells is a Biologic drug developed by Clinica Universidad de Navarra, Universidad de Navarra.
Who makes Hiltonol and autologous dendritic cells?
Hiltonol and autologous dendritic cells is developed by Clinica Universidad de Navarra, Universidad de Navarra (see full Clinica Universidad de Navarra, Universidad de Navarra pipeline at /company/clinica-universidad-de-navarra-universidad-de-navarra).
What development phase is Hiltonol and autologous dendritic cells in?
Hiltonol and autologous dendritic cells is in Phase 2.